Sejal Kadakia
Pediatric Endocrinology · Orange, CANPI 1952692089
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $679 and has fallen 59.7% since, to $274 in 2025.
Across 100 payments — averaging $23.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ascendis Pharma Endocrinology Inc$336
- AbbVie$198
- Novo Nordisk$187
- Medtronic$174
- Arbor Pharmaceuticals, Inc.$171
- Lilly USA, LLC$137
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,30098%
- Education$352%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 11 | $336 |
| AbbVie | 9 | $198 |
| Novo Nordisk | 8 | $187 |
| Medtronic(2 entities) | 7 | $174 |
| Arbor Pharmaceuticals, Inc. | 9 | $171 |
| Lilly USA, LLC | 7 | $137 |
| Ipsen Biopharmaceuticals, Inc | 4 | $135 |
| Dexcom, Inc. | 5 | $103 |
| Neurocrine Biosciences, Inc. | 3 | $93 |
| Tandem Diabetes Care, Inc. | 4 | $90 |
| BD | 2 | $72 |
| Rhythm Pharmaceuticals, Inc. | 3 | $72 |
| Pfizer | 3 | $56 |
| Tolmar, Inc. | 1 | $49 |
| Eton Pharmaceuticals, Inc. | 2 | $49 |
| AstraZeneca | 2 | $46 |
| Travere Therapeutics, Inc. | 6 | $37 |
| BETA Bionics, Inc. | 1 | $30 |
| Embecta Corp. | 1 | $29 |
| Abbott | 1 | $29 |
| Insulet Corporation | 1 | $29 |
| Companion Medical, Inc. | 1 | $26 |
| Sequel Med Tech, LLC | 1 | $26 |
| Biomarin Pharmaceutical Inc. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| Galen US Inc | 1 | $21 |
| Mannkind Corporation | 1 | $21 |
| Sanofi | 1 | $18 |
| Amryt Pharma Holdings Ltd | 1 | $17 |
| Senseonics, Incorporated | 1 | $17 |
How this compares
$2,336 in reported general payments places this provider in the 60th percentile of 168 pediatric endocrinology providers in California.
Other pediatric endocrinology in Orange
- Lynda PolgreenOrange$167K
- Timothy FlanneryOrange$32K
- Himala KashmiriOrange$5K
- Daina DreimaneOrange$3K
- Nikita ForghaniOrange$3K
- Lien TrinhOrange$3K
- Gnanagurdasan PrakasamSacramento$805K
- Swati ElchuriVentura$210K
- Karen KleinSan Diego$195K
- Francine KaufmanLos Angeles$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.